Department of General and Visceral Surgery, University of Freiburg, Freiburg, Germany.
Digestion. 2009;80(2):65-73. doi: 10.1159/000212080. Epub 2009 Jun 3.
BACKGROUND/AIMS: Severe lung injury, responsible for up to 15% of mortality in acute necrotizing pancreatitis patients, is promoted by neutrophil (PMN) migration into the lung. We have previously demonstrated that pulmonary injury in acute pancreatitis is mediated by PMN-derived matrix metalloproteinase-9 (MMP-9). This study was conducted to evaluate the ability of the broad-spectrum MMP inhibitor doxycycline to prevent secondary pulmonary injury in acute pancreatitis.
Eighteen rats were randomized into three groups: severe pancreatitis (SAP), severe pancreatitis + doxycycline (SAP+Dox) (30 mg/kg body mass) or control. Acute pancreatitis was induced by intraductal glycodesoxycholic acid and i.v. stimulation with cerulein. Lung sections were histologically graded for edema, microthrombi, atelectasis and hemorrhage. Active MMP-9 in lung tissue was measured with fluorescent assay (ELISA). Naphtol-AS-D-chloroacetate esterase staining was used to determine pulmonary PMN infiltration. The inhibitory effect of doxycycline on MMP-9-induced transmigration was confirmed in a Matrigel transmigration assay.
Addition of doxycycline significantly reduced TNF-alpha-induced PMN transmigration across Matrigel membrane (12.6 +/- 2.6 vs. 20.1 +/- 3.9 PMNs; p < 0.05). SAP+Dox showed decreased concentration of active MMP-9 in lung tissue (37.89 +/- 1.75 vs. 46.29 +/- 3.68 ng/ml; p < 0.05) and as a result decreased pulmonary infiltration of PMNs (21.2 +/- 5.1 vs. 32.5 +/- 6.8; p < 0.05). Histological evaluation revealed decreased pulmonary edema (1.83 +/- 0.41 vs. 2.33 +/- 0.51, p < 0.05), atelectasis (1.67 +/- 0.52 vs. 2.33 +/- 0.52; p < 0.05) and pulmonary hemorrhage (2.5 +/- 0.55 vs. 1.83 +/- 0.41; p < 0.05) in SAP+Dox vs. SAP. These findings were paralleled by reduced pulmonary expression of active MMP-9.
Inhibition of MMP-9 activity with doxycycline reduced pancreatitis-associated lung injury and expression of MMP-9 in pulmonary tissue. Doxycycline reduced PMN migration in vitro and in vivo and therefore might represent a novel strategy for the prevention of secondary pulmonary complications in acute pancreatitis.
背景/目的:中性粒细胞(PMN)向肺部迁移导致急性坏死性胰腺炎患者的死亡率高达 15%,严重的肺损伤是其主要原因。我们之前的研究表明,急性胰腺炎中的肺损伤是由PMN 衍生的基质金属蛋白酶-9(MMP-9)介导的。本研究旨在评估广谱 MMP 抑制剂强力霉素预防急性胰腺炎继发肺损伤的能力。
将 18 只大鼠随机分为三组:重症胰腺炎(SAP)组、重症胰腺炎+强力霉素(SAP+Dox)组(30mg/kg 体重)和对照组。通过胰管内甘氨脱氧胆酸诱导和静脉内给予 Cerulein 刺激诱导急性胰腺炎。对肺组织切片进行水肿、微血栓、肺不张和出血的组织学分级。用荧光测定法(ELISA)测量肺组织中的活性 MMP-9。萘基-AS-D-氯乙酸酯酶染色用于确定肺 PMN 浸润。在 Matrigel 迁移测定中证实了强力霉素对 MMP-9 诱导的迁移的抑制作用。
强力霉素的加入显著降低了 TNF-α诱导的 PMN 通过 Matrigel 膜的迁移(12.6±2.6 对 20.1±3.9 PMNs;p<0.05)。SAP+Dox 组肺组织中活性 MMP-9 的浓度降低(37.89±1.75 对 46.29±3.68ng/ml;p<0.05),PMN 浸润减少(21.2±5.1 对 32.5±6.8;p<0.05)。组织学评估显示,SAP+Dox 组肺水肿(1.83±0.41 对 2.33±0.51,p<0.05)、肺不张(1.67±0.52 对 2.33±0.52;p<0.05)和肺出血(2.5±0.55 对 1.83±0.41;p<0.05)均较 SAP 组减少。这些发现与肺组织中活性 MMP-9 的表达减少相平行。
强力霉素抑制 MMP-9 活性可减轻胰腺炎相关的肺损伤和肺组织中 MMP-9 的表达。强力霉素减少了 PMN 的迁移,无论是在体外还是在体内,因此可能成为预防急性胰腺炎继发肺部并发症的一种新策略。